PCT and TRT on TikTok: separating protocol from hype

What did @dpromethod actually say?

The creator's core claim is that natural testosterone production can sometimes restart after TRT, but "it's not automatic." They explain that TRT suppresses the hypothalamic-pituitary-testicular axis (HPTA), and that recovery requires stimulating LH and FSH production using specific compounds. They name HCG and Clomid as the primary tools for what they call a "restart" or post-cycle therapy (PCT). They also acknowledge that outcomes vary by age, genetics, and duration of TRT use, and close with a reasonable warning: "TRT should never be started casually because coming off isn't guaranteed." That's a more responsible framing than you typically see in this corner of TikTok.

One note on transcript accuracy: the creator says "Chlamid" which is clearly a mispronunciation of Clomid (clomiphene citrate). Worth flagging, not to be pedantic, but because confusion around drug names in health content has real consequences.

Does the science back this up?

Mostly, yes. The suppression mechanism is well-established, and the recovery data, while limited, does support the idea that some men can restore endogenous production. The devil is in the details.

Exogenous testosterone suppresses gonadotropin-releasing hormone (GnRH) pulsatility, which in turn shuts down LH and FSH secretion from the pituitary. Without LH and FSH, the testes stop producing testosterone and sperm. This is documented thoroughly. A 2000 study by Bhasin et al. in the Journal of Clinical Endocrinology and Metabolism confirmed dose-dependent suppression of LH and FSH with exogenous testosterone administration.

Recovery rates after TRT cessation are real but inconsistent. Liu et al. (2006, Journal of Clinical Endocrinology and Metabolism) found that most healthy men recovered spermatogenesis within one to two years after stopping testosterone, but not all. Age and duration of use were significant predictors, exactly what the creator says. HCG is supported for maintaining or restoring testicular function. Clomiphene (Clomid) has evidence as a testosterone-stimulating agent, though most studies focus on its use as a primary treatment rather than a PCT tool specifically.

What did they get wrong, or right?

They got the core biology right. The HPTA suppression mechanism, the role of LH and FSH, and the variability in recovery outcomes are all accurate. Credit where it's due.

What's missing or imprecise: the creator lumps TRT patients and "testosterone blasters" together as if their recovery prospects are comparable. They are not. Someone on a therapeutic dose of testosterone for diagnosed hypogonadism for two years is in a very different physiological situation than someone who has run multiple high-dose anabolic steroid cycles. Recovery data from PCT studies in the bodybuilding context does not cleanly transfer to clinical TRT patients, and conflating the two is a meaningful error of omission.

The Clomid claim is also incomplete. Clomiphene has decent evidence as a standalone treatment for secondary hypogonadism (Katz et al., 2012, BJU International), but its effectiveness as a PCT agent after prolonged TRT is less established. Presenting it as a routine restart tool without that caveat oversimplifies the clinical picture.

HCG use is more defensible, particularly for maintaining testicular volume and function during TRT, as shown by Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism).

What should you actually know?

If you're considering stopping TRT, the honest answer is that no one can guarantee your axis will recover, and the timeline varies widely. Studies suggest younger men with shorter durations of use have better odds, but individual variation is significant enough that population-level data only tells you so much about your specific situation.

Recovery attempts should happen under medical supervision. HCG and clomiphene are prescription medications with their own side effect profiles. HCG can cause estradiol elevation; clomiphene has reported visual side effects and mood effects in a subset of users. These are not over-the-counter supplements.

There's also a clinical reality the video doesn't address: some men who go on TRT do so because their endogenous production was already compromised before treatment. For those men, a "restart" was never really on the table. That's why baseline testing before starting TRT matters, and why the creator's closing line, that TRT should never be started casually, is probably the most useful thing they said in the whole video.

• If you want to explore a restart, ask your prescriber about baseline LH, FSH, and testicular volume before stopping TRT.
• Expect a recovery window of three to twelve months minimum if it's going to happen at all.
• PCT protocols are not standardized in clinical medicine. What works in anabolic steroid recovery research does not automatically apply to TRT patients.